RecruitingNCT07059923

Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)


Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Enrollment

400 participants

Start Date

Jul 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

CT imaging data from lung cancer (NSCLC and SCLC) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients were treated for lung cancer in Wuhan Union Hospital from July 2025 to July 2026;
  • Aged \> 18 years old;
  • At least one CT scan before treatment;
  • Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

Exclusion Criteria4

  • Poor image quality;
  • Incomplete clinical data or loss of follow-up;
  • Presence of another primary malignancy other than lung cancer;
  • Unclear pathological diagnosis.

Locations(1)

Union Hospital,Tongji Medical College,Huazhong University of Science and Technology

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07059923


Related Trials